SCHEMBL8105568

SCHEMBL8105568

CC(C)(C)c1nc(C(C)(C)C)n(Cc2ccc(Cc3ccccc3C(=O)O)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
GRN P28799 2/20 0.42
SORT1 Q99523 2/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
AGTR1 P30556 3/20 0.39
AGTR2 P50052 3/20 0.39
CYP2C9 P11712 1/20 0.37
HIF1A Q16665 1/20 0.37
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
FOLH1 Q04609 1/20 0.36
MEN1 O00255 1/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8109231 0.88 TSHR (0.41) TSHRGRNSORT1CA1CA2
SCHEMBL6004646 0.84 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL8096138 0.81 GRN (0.44) GRNSORT1CA1CA2CA9
SCHEMBL6004893 0.77 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL8104929 0.77 AGTR1 (0.44) TSHRAGTR1AGTR2
SCHEMBL8109371 0.76 PPARG (0.48) GRNSORT1
SCHEMBL8104938 0.75 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL6004887 0.75 AGTR1 (0.67) AGTR1AGTR2
SCHEMBL6858399 0.75 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL8096148 0.74 CNR2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed